title: Vinorelbine: friend or foe?
authors.forename: J H P
authors.initials: JH
authors.lastname: Robertson
authors.forename: A
authors.initials: A
authors.lastname: Dixit
authors.forename: A
authors.initials: A
authors.lastname: Smith
authors.forename: P G
authors.initials: PG
authors.lastname: Harper
mesh_terms: D015746:Abdominal Pain; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary; D001943:Breast Neoplasms / Q000188:drug therapy*; D002277:Carcinoma / Q000188:drug therapy*; D018450:Disease Progression; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary; D008875:Middle Aged; D009362:Neoplasm Metastasis; D014747:Vinblastine / Q000009:adverse effects / Q000031:analogs & derivatives*; D000077235:Vinorelbine
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D014747:Vinblastine; D000077235:Vinorelbine